Search
for
Sort by
Research 511–540 of 1000+
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Frontal fibrosing alopecia: a disease fascinating for the researcher, disappointing for the clinician and distressing for the patient
- Acne exacerbation after tofacitinib treatment for alopecia areata
- Management of folliculitis decalvans: The EADV task force on hair diseases position statement
- Refractory alopecia in lupus treated with tofacitinib — a case-based review
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Global burden of alopecia areata from 1990 to 2019 and emerging treatment trends analyzed through GBD 2019 and bibliometric data
- The Relative Efficacy and Safety of Monotherapies for Alopecia Areata: A Network Meta‐Analysis Study
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- What’s New in Hair Loss
- Taiwanese Dermatological Association consensus on the diagnosis and management of alopecia areata
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Efficacy and Potential Mechanisms of Naringin in Atopic Dermatitis
- Biologics in the management of childhood atopic dermatitis
- Ruxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
- Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review
- Hypohidrotic Ectodermal Dysplasia with c.28delG Mutation in Ectodysplasin A Gene and Severe Atopic Dermatitis Treated Successfully with Tofacitinib
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- Seborrheic Dermatitis Revisited: Pathophysiology, Diagnosis, and Emerging Therapies—A Narrative Review
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
- Good efficacy achieved by baricitinib in the treatment of anti-MDA5 antibody-positive dermatomyositis with alopecia areata
- Alopecia areata: medical treatments
- Alopecias in humans: biology, pathomechanisms and emerging therapies
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- Alopecia Areata: A Complex Cytokine Driven Disease
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Clinical Features and Treatment Options of Vogt-Koyanagi-Harada Disease
- Alopecia Areata of the Nails: Diagnosis and Management